These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 5722983)

  • 21. [Indications and treatment of menstrual disorders with a synthetic progestational hormone, ethynodiol diacetate alone or combined in variable doses with an estrogen].
    Soutoul JH
    Rev Fr Gynecol Obstet; 1969; 64(1):41-55. PubMed ID: 5362109
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ovulen in the treatment of the premenstrual syndromes in psychiatric patients].
    Rasmussen R; Hagen A; Ravn J
    Ugeskr Laeger; 1967 Feb; 129(7):224-6. PubMed ID: 5599219
    [No Abstract]   [Full Text] [Related]  

  • 23. [COLPOSCOPIC, CYTOLOGIC AND HISTOLOGIC FINDINGS IN THE PORTIO UTERI DURING OVULATION INHIBITING MEDICATION].
    DONTENWILL W
    Munch Med Wochenschr; 1965 Mar; 107():491-2. PubMed ID: 14266626
    [No Abstract]   [Full Text] [Related]  

  • 24. [FH 027 in the treatment of dysmenorrhea].
    Kolenc M
    Bord Med; 1970 May; 3(5):1409-10. PubMed ID: 5425890
    [No Abstract]   [Full Text] [Related]  

  • 25. [The antiovulatory or ovariostatic drugs].
    Nizza M
    Minerva Med; 1968 May; 59(40 Suppl):24-7. PubMed ID: 5657602
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical study of a low dosage estrogen-progestational combination (FH 027-A)].
    Villedieu P
    Rev Fr Gynecol Obstet; 1968 Jun; 63(6):329-36. PubMed ID: 5711745
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tolerance of the gestagen-estrogen combination Noracyclin in contraception and gynecologic indications].
    Willmes HG
    Med Klin; 1967 Jun; 62(24):951-4. PubMed ID: 5627276
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical study of a synthetic progestagen at low doses].
    Gaudefroy M
    Gynecol Prat; 1966; 17():337-43. PubMed ID: 5987259
    [No Abstract]   [Full Text] [Related]  

  • 29. The problem of period control in disabled women.
    Hamilton EA; Nichols PJ
    Ann Phys Med; 1968 Aug; 9(7):288-94. PubMed ID: 4234086
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long term treatment with ovulation inhibitors. Endometrium, cervix and vaginal epithelium after cyclic long term treatment with a progestagen-estrogen mixture for ovulation inhibition (histological, cytological and colposcopic findings].
    Breinl H; Warnecke W
    Med Klin; 1967 Nov; 62(47):1835-9. PubMed ID: 5588929
    [No Abstract]   [Full Text] [Related]  

  • 31. [The menstrual cycle after oral contraceptives].
    Hauser GA; Girotti M
    Geburtshilfe Frauenheilkd; 1967 Jun; 27(6):626-30. PubMed ID: 5592760
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of Sc. 11800 (ethynodiol diacetate) on the genital tract of women.
    Shahani S; Chiklikar A
    J Reprod Fertil; 1967 Aug; 14(1):1-4. PubMed ID: 6067922
    [No Abstract]   [Full Text] [Related]  

  • 33. [STUDIES ON THE ACTION AND SIDE EFFECTS OF NORETHYNODREL AND ETHYNODIOL DIACETATE].
    SOOST HJ; MEHRING W
    Bibl Gynaecol; 1965; 32():183-7. PubMed ID: 14238631
    [No Abstract]   [Full Text] [Related]  

  • 34. [Colposcopic and cytologic findings following Antigest administration].
    Skácel K; Heczko P; Pĕcka V
    Cesk Gynekol; 1967 Apr; 32(3):209-11. PubMed ID: 6082993
    [No Abstract]   [Full Text] [Related]  

  • 35. [Norsteroids in gynaecological therapy (author's transl)].
    Dvorák K; Cernoch A
    Cesk Gynekol; 1973 Sep; 38(8):620-1. PubMed ID: 4765141
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical study of a synthetic estro-progestational agent: FH 080].
    Villedieu P
    Presse Med (1893); 1966 Nov; 74(51):2625-6. PubMed ID: 5926994
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of synthetic steroid preparations for hemostasis and normalization of menstrual function in juvenile hemorrhages].
    Kuznetsova MN; Antipina NN; Zagorskaia EA
    Vopr Okhr Materin Det; 1978 Feb; 23(2):77-80. PubMed ID: 347706
    [No Abstract]   [Full Text] [Related]  

  • 38. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology].
    Bernard I
    Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ethynodiol diacetate in the treatment of pelvi-genital endometriosis].
    Rochet Y; Lansac J; Su SE
    Rev Fr Gynecol Obstet; 1974; 69(7-9):509-11. PubMed ID: 17436515
    [No Abstract]   [Full Text] [Related]  

  • 40. Indications for therapy with progestational agents.
    Darragh A
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):541-4. PubMed ID: 5534331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.